Related Experiment Video
Updated: Jun 5, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Synthetic approaches to the 2009 new drugs
Kevin K-C Liu1, Subas M Sakya, Christopher J O'Donnell
1Pfizer Inc., La Jolla, CA 92037, USA. Kevin.k.liu@pfizer.com
Abstract:
New drugs are introduced to the market every year and each individual drug represents a privileged structure for its biological target. These new chemical entities (NCEs) provide insights into molecular recognition and also serve as leads for designing future new drugs. This review covers the syntheses of 21 NCEs marketed in 2009.
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Pharmacogenomics: Identification of New Drug Targets
Drug Products: Biologics, Biosimilars and Interchangeables
Prodrugs
Prodrugs help overcome...
